Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban

BACKGROUND: Low-molecular-weight heparins (e.g. Enoxaparin) are widely used to prevent venous thromboembolism after orthopaedic surgery, but there are reports about serious side effects including reduction in bone density and strength. In recent years new oral antithrombotic drugs (e.g. direct Facto...

Descripción completa

Detalles Bibliográficos
Autores principales: Pilge, Hakan, Fröbel, Julia, Mrotzek, Silvia J., Fischer, Johannes C., Prodinger, Peter M., Zilkens, Christoph, Bittersohl, Bernd, Krauspe, Rüdiger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772441/
https://www.ncbi.nlm.nih.gov/pubmed/26927834
http://dx.doi.org/10.1186/s12891-016-0966-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772441/
https://www.ncbi.nlm.nih.gov/pubmed/26927834
http://dx.doi.org/10.1186/s12891-016-0966-2

Ejemplares similares